WO2011023105A1 - Intravascular reconstructive stent - Google Patents

Intravascular reconstructive stent Download PDF

Info

Publication number
WO2011023105A1
WO2011023105A1 PCT/CN2010/076333 CN2010076333W WO2011023105A1 WO 2011023105 A1 WO2011023105 A1 WO 2011023105A1 CN 2010076333 W CN2010076333 W CN 2010076333W WO 2011023105 A1 WO2011023105 A1 WO 2011023105A1
Authority
WO
WIPO (PCT)
Prior art keywords
stent
vascular remodeling
stent according
remodeling
vascular
Prior art date
Application number
PCT/CN2010/076333
Other languages
French (fr)
Chinese (zh)
Inventor
刘建民
罗七一
谢志永
李�雨
王森
李建军
金巧蓉
向勇刚
Original Assignee
微创医疗器械(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 微创医疗器械(上海)有限公司 filed Critical 微创医疗器械(上海)有限公司
Publication of WO2011023105A1 publication Critical patent/WO2011023105A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2002/823Stents, different from stent-grafts, adapted to cover an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0023Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in porosity

Definitions

  • the present invention relates to an intravascular implant device, and more particularly to a vascular remodeling stent capable of altering blood flow of a lesion, which can be implanted into a blood vessel for treating a lesion such as an vascular dilatation, deformation, or deformity, such as an aneurysm.
  • a vascular remodeling stent capable of altering blood flow of a lesion, which can be implanted into a blood vessel for treating a lesion such as an vascular dilatation, deformation, or deformity, such as an aneurysm.
  • Aneurysm Due to factors such as disease, injury or congenital local weakness, under the impact of long-term blood flow, the weak point of the arterial wall protrudes outward and gradually expands to form a round, elliptical or prismatic bulge.
  • An aneurysm is a potentially life-threatening disease. An aneurysm grows under the impact of blood flow. When an aneurysm breaks due to high blood pressure or other factors, sharp bleeding occurs. The ruptured aneurysm is extremely high. Causing mortality. Aneurysms can occur in different parts of the body, most commonly cerebral aneurysms and abdominal aortic aneurysms.
  • the cerebral artery wall is thin, complex in distortion, large in curvature, high in bifurcation, sensitive to stimuli, and lack of tissue support around it.
  • the most common cerebral aneurysms usually occur in the branching, bifurcation or bending of blood vessels, mainly due to the hemodynamic factors of the site, that is, the impact of axial blood flow on the distal end of the blood vessel to form shear stress, resulting in the elastic layer of blood vessels.
  • the destruction, the formation of ridges, and shear stress stimulation promote the division and growth of damaged vascular endothelial cells, and then grow into an aneurysm, this shear stress is the basic cause of aneurysm formation.
  • the blood formed in the aneurysm is disordered, forming eddy currents, inducing fluid resonance, triggering oscillation of the blood vessel wall and promoting denaturation, growth and rupture.
  • aneurysm treatment includes: 1. surgically clamping an aneurysm, clamping the aneurysm neck with a metal clip through craniotomy; 2. endovascular intervention, using a detachable coil (or microwire ring or Other embolic materials such as detachable globules, curable fluids, etc.) embolization of aneurysms; 3. Endovascular interventional stent implantation. Due to the traumatic, high-risk and high-complication of surgical treatment, endovascular intervention has gradually become the main method of aneurysm treatment, which has less trauma, less complications, high safety, less patient pain, easy acceptance, and hospitalization time. Short, high-grade illness can also tolerate and other advantages.
  • the detachable coil is filled with a percutaneous vascular puncture, which is introduced into the blood vessel through a microcatheter, and a metal coil is placed in the aneurysm to fill the aneurysm, thereby preventing blood flow into the aneurysm.
  • Coil Embolization materials and microcatheters are designed to reach aneurysmal lesions that distort complex cerebral arteries and block blood flow impact through the filling of the tumor lumen. However, this packing also carries the risk of further enlargement and rupture of the aneurysm lumen.
  • the goal of aneurysm treatment is to reduce the risk of aneurysm rupture.
  • the most fundamental method is to achieve the healing of the parental artery and the reconstruction of the anatomy of the artery wall.
  • the stent can be compressed into the lumen of the microconveyor. After compression, the stent is soft enough to be transported through the tortuous, slender, complex cerebrovascular vessels to the target;
  • the stent mesh significantly affects the hemodynamics within the aneurysm while maintaining the patency of the normal branch artery covered by the stent.
  • the coronary stent is implanted into the cerebral artery of the cerebral aneurysm to assist the coil embolization.
  • the anatomy of the cerebral blood vessels is complex and has more curvature than the coronary arteries, so the rigidity of the coronary stent makes it very difficult to reach the cerebral blood vessels.
  • the present invention provides a highly flexible and flexible vascular remodeling stent capable of traversing a tortuous and delicate cerebral blood vessel to reach a target lesion, and conforming to a tortuous blood vessel to maintain a lumen of the blood vessel. Road.
  • the stent has a high-density mesh that can significantly alter the flow of blood in the aneurysm to cause it to form blood clots and mechanized solids.
  • the vascular remodeling stent of the present invention can be implanted into a blood vessel for treating a lesion such as a vasodilatation, a deformity, a deformity, or the like, such as an aneurysm or the like.
  • the vascular remodeling stent has a mesh tubular structure and has a plurality of meshes formed by interlacing a plurality of silk chains. Wherein each of the chains is continuous and the nodes of the mesh are movable.
  • the silk chain refers to a silk or filament structure.
  • the silk chain forms an angle ⁇ 0 with the radial direction of the vascular remodeling stent, and the angle ⁇ 0 is 15. ⁇ 85. . It is preferably 30. ⁇ 75. More preferably, it is 45. ⁇ 60.
  • the goal is to maintain a proper support of the vascular remodeling stent while providing optimal adherence and compliance within the curved vessel for vascular remodeling.
  • the vascular remodeling stent has a mesh density greater than 5 pores/mm 2 .
  • the metal coverage of the vascular remodeling stent is 12% to 60%, preferably 30% to 50%, more preferably 35% to 45%.
  • vascular remodeling stent Depending on the implantation and treatment site of the vascular remodeling stent, different portions of the vascular remodeling stent have different metal coverage.
  • the metal coverage of the vascular remodeling stent varies in the axial direction. At the aneurysm segment, the metal coverage is 30% to 50%, and at other locations, the metal coverage is 12% to 20%.
  • the metal coverage of the vascular remodeling stent varies in the circumferential direction. At the aneurysm mouth, the metal coverage is 50% to 60%, and at other locations, the metal coverage is 12% to 20%.
  • the compression ratio of the vascular reconstruction scaffold can reach 2:1 - 10:1.
  • the number of strands is from 8 to 108, preferably from 24 to 96, more preferably from 32 to 56, in order to achieve an optimal balance of support and compliance of the vascular remodeling stent.
  • the cross-section of the wire chain may be a different shape such as a rectangle, a trapezoid, a circle or an ellipse or the like.
  • the diameter of the wire chain is 0.01 to 0.2 mm, preferably 0.025 to 0.1 mm, more preferably 0.03 to 0.08 mm.
  • the cross section of the wire chain is rectangular, the length and width of the rectangle are 0.01 to 0.2 mm, preferably 0.025 to 0.1 mm, more preferably 0.03 to 0.08 mm, and the aspect ratio of the rectangle is 1:1 to 4:1.
  • the purpose of determining the size of the silk chain in this way is to ensure that the silk of the vascular remodeling stent has a suitable mechanical strength, and can effectively eliminate the influence of the small perforating artery in the intracranial artery (the diameter of the perforating artery is usually larger than 0.1 mm).
  • the pitch of the wire chain is 0.01 to 3 mm.
  • the silk chains can have different pitches depending on the implantation and treatment sites of the vascular remodeling stent.
  • pitch refers to the distance traveled by any point on a single wire chain after 2 ⁇ .
  • the material of the silk chain may be a biocompatible metal or/and a polymer.
  • the above-mentioned vascular remodeling stent can be used to support or block the embolic material in the aneurysm to ensure that the embolic material is only in the aneurysm and maintain the patency of the parent artery.
  • the vascular remodeling stent of the present invention is highly flexible and flexible, and is capable of traversing a tortuous and delicate cerebral blood vessel to reach a target lesion, and conforms to a tortuous blood vessel to maintain a vascular lumen passage.
  • continuously variable high-density meshes can significantly alter blood flow in the aneurysm to cause it to form blood clots and mechanized solids.
  • high-density mesh as a support for endothelial cell growth or migration can accelerate the growth process of the intima, and the retention of blood flow in the aneurysm ensures the physical conditions of intimal growth, making the diseased vessel intimalization real. Anatomical cure.
  • FIG. 1 is a schematic structural view of a preferred embodiment of a vascular remodeling stent according to the present invention
  • FIG. 2 is a perspective view showing a structure of a preferred embodiment of a vascular remodeling stent according to the present invention
  • FIG. 3 is a vascular remodeling stent according to the present invention.
  • a partially enlarged schematic view of a preferred embodiment
  • Figure 4 is a schematic illustration of the use of a preferred embodiment of a vascular remodeling stent in accordance with the present invention
  • Figures 5a, 5b are schematic illustrations of other preferred embodiments of a vascular remodeling stent in accordance with the present invention
  • _ 6d is a schematic cross-sectional view of different silk chains of a vascular remodeling stent according to the present invention. Description of the reference numerals
  • vascular remodeling stent 10 shown in the drawing is a mesh tubular structure formed by interlacing a continuous filament chain 20 having a plurality of meshes.
  • the braided points of the chain 20 interlaced are also referred to as the nodes of the mesh, and the nodes 30 of the mesh are movable or movable.
  • Each of the strands 20 of the stent forms an angle ⁇ with the radial direction of the stent. , angle ⁇ . It is from 15 ° to 85 °, preferably from 30 ° to 75 °, more preferably 45. ⁇ 60. This provides sufficient diameter/loop support.
  • the wire chain 20 is not fixed to the nodes, and the wire chains 20 can move relative to each other.
  • the relative mobility of the wire chain 20 allows the stent to be flexible enough to flex or twist the space to be closer to the natural vessel morphology, conforming to and conforming to the tortuous cerebrovascular vessels while maintaining the intravascular lumen morphology.
  • the mesh density of the stent ie, the number of cells per unit area
  • the mesh density of the stent is greater than 5 pores/mm 2 .
  • the stent metal coverage is 12% to 60%, preferably 30% to 50%, more preferably 35% to 45%.
  • the number of the chains used for weaving may be from 8 to 108, preferably from 24 to 96, more preferably from 32 to 56. Depending on the implantation and treatment site of the stent, there may be different numbers of silk chains.
  • the pitch of the wire chain is preferably controlled to be 0.01 to 3 mm.
  • the metal coverage and mesh density of the stent can be achieved by the number of braided chains, the size, the weaving pitch, and the like.
  • pitch refers to the distance traveled by any point on a single wire chain after 2 ⁇ . For example, the distance between nodes 31 and 32 in Figure 3.
  • the stent of the present invention has a soft continuous structure and high compressibility, and the compression ratio can reach 2:1 to 10:1, and can be compressed and loaded into the diameter ⁇ of 0.3 mm to 1.5 mm. Inside the conveyor, the stent can pass through the tortuous, slender cerebrovascular.
  • the vascular remodeling stents 40, 50 have a non-uniform grid structure, i.e., the stents have different metal coverage at different locations.
  • the aneurysm segments 41, 51 covering the parent artery 43, 53 have a high metal coverage to maximize blood flow in the aneurysm, while the other portions of the stent 42, 52 have a low metal coverage structure.
  • the normal vessel wall 45, 55 is attached with a support bracket to minimize the coverage of the branches 44, 54 while keeping the lumen open.
  • the metal coverage is 30% to 50%, and at other locations, the metal coverage is 12% to 20%.
  • the metal coverage can vary in the circumferential direction of the stent. At the aneurysm of the aneurysm segment, the metal coverage is 50% to 60%, and at other locations, the metal coverage is 12% to 20%.
  • the cross-section of the wire chain can be of a different shape, such as rectangular, trapezoidal, circular or elliptical.
  • the continuous mesh of the implant device can also be used as an embolization material in the aneurysm (such as a releasable coil, embolic fluid, etc.) to support or block, to ensure that the embolic material is only in the aneurysm, thereby maintaining the tumor.
  • embolization material such as a releasable coil, embolic fluid, etc.

Abstract

A vascular remodeling stent (10, 40, 50) has a mesh tubular structure which includes multiple pores formed by interleaved braiding several filaments (20). Every filament is continuous and the nodes (30) of the pores are moveable. The vascular remodeling stent is soft and flexible to pass through sinuous and tenuous brain blood vessels and reach the target diseased part, and is compliant with derious blood vessels to maintain the lumen passage in blood vessels. Furthermore, the stent includes pores with high density, and can remarkably change the blood stream in the aneurysm to stagnate the blood to form blood clots and organized thrombus.

Description

一种血管重构支架 本申请要求于 2009 年 08 月 27 日提交中国专利局、 申请号为 200910194688.0、 发明名称为 "一种血管重构支架"的中国专利申请的优先 权, 其全部内容通过引用结合在本申请中。 技术领域  The present invention claims priority to Chinese Patent Application No. 200910194688.0, entitled "A Vascular Remodeling Stent", filed on August 27, 2009, the entire contents of which are hereby incorporated by reference. Combined in this application. Technical field
本发明涉及一种血管内植入装置, 特别是一种可改变病变血流的血管 重构支架, 其可植入血管内用于治疗血管扩张、 变形、 畸形等病变, 例如 动脉瘤等。 背景技术  The present invention relates to an intravascular implant device, and more particularly to a vascular remodeling stent capable of altering blood flow of a lesion, which can be implanted into a blood vessel for treating a lesion such as an vascular dilatation, deformation, or deformity, such as an aneurysm. Background technique
血管壁, 特别是动脉血管壁可能发生局部异常的扩张或凸起, 我们称 之为动脉瘤。 由于疾病、 损伤或先天等因素导致局部的薄弱, 在长期血流 的冲击下, 该处动脉壁的薄弱点向外突出, 逐渐扩张, 形成圆形、 椭圆形 或棱形的嚢状膨出。 动脉瘤是一种有潜在生命危险的疾病, 动脉瘤在血流 的冲击下不断生长, 当由于血压增高或其他因素引起的动脉瘤破裂时, 会 发生急剧的出血, 破裂动脉瘤具有极高的致死亡率。 动脉瘤可发生在身体 的不同部位, 最常见为脑动脉瘤和腹主动脉瘤。  Local abnormal augmentation or bulging may occur in the vessel wall, particularly the arterial vessel wall, which we call an aneurysm. Due to factors such as disease, injury or congenital local weakness, under the impact of long-term blood flow, the weak point of the arterial wall protrudes outward and gradually expands to form a round, elliptical or prismatic bulge. An aneurysm is a potentially life-threatening disease. An aneurysm grows under the impact of blood flow. When an aneurysm breaks due to high blood pressure or other factors, sharp bleeding occurs. The ruptured aneurysm is extremely high. Causing mortality. Aneurysms can occur in different parts of the body, most commonly cerebral aneurysms and abdominal aortic aneurysms.
脑动脉壁较薄, 迂曲复杂、 弯曲度大、 分叉多、 对刺激敏感、 其周围 缺乏组织支撑等。 最常见的脑动脉瘤一般发生在血管分支、 分叉或弯曲部 位, 主要是由于该部位的血流动力学因素, 即轴向血流对血管远端的冲击 形成剪切应力, 导致血管弹力层的破坏, 形成嚢状突起, 同时剪切应力刺 激促进受损的血管内皮细胞分裂生长, 进而生长成动脉瘤, 这种剪应力是 动脉瘤形成的基本原因。 形成的动脉瘤内血液发生紊乱, 形成涡流, 诱导 流体共振, 引发血管壁振荡并促进其变性、 生长、 破裂。  The cerebral artery wall is thin, complex in distortion, large in curvature, high in bifurcation, sensitive to stimuli, and lack of tissue support around it. The most common cerebral aneurysms usually occur in the branching, bifurcation or bending of blood vessels, mainly due to the hemodynamic factors of the site, that is, the impact of axial blood flow on the distal end of the blood vessel to form shear stress, resulting in the elastic layer of blood vessels. The destruction, the formation of ridges, and shear stress stimulation promote the division and growth of damaged vascular endothelial cells, and then grow into an aneurysm, this shear stress is the basic cause of aneurysm formation. The blood formed in the aneurysm is disordered, forming eddy currents, inducing fluid resonance, triggering oscillation of the blood vessel wall and promoting denaturation, growth and rupture.
动脉瘤治疗的通常方法包括: 1. 外科手术夹闭动脉瘤, 通过开颅手术 用金属夹子夹闭动脉瘤颈部; 2. 血管内介入治疗, 利用可脱卸弹簧圈 (或 微金属丝圈或其他栓塞材料如可解脱球嚢、 可固化液体等)栓塞动脉瘤; 3. 血管内介入治疗支架植入术。 由于外科治疗的创伤性、 高风险性及高并发症, 血管内介入治疗逐渐 成为动脉瘤治疗的主要方法, 其具有创伤小、 并发症少、 安全性高、 患者 痛苦少、 易接受、 住院时间短、 年高病情重也能耐受等优势。 Common methods of aneurysm treatment include: 1. surgically clamping an aneurysm, clamping the aneurysm neck with a metal clip through craniotomy; 2. endovascular intervention, using a detachable coil (or microwire ring or Other embolic materials such as detachable globules, curable fluids, etc.) embolization of aneurysms; 3. Endovascular interventional stent implantation. Due to the traumatic, high-risk and high-complication of surgical treatment, endovascular intervention has gradually become the main method of aneurysm treatment, which has less trauma, less complications, high safety, less patient pain, easy acceptance, and hospitalization time. Short, high-grade illness can also tolerate and other advantages.
可脱卸弹簧圈填塞瘤腔是经皮血管穿刺, 通过微导管导入血管, 将金 属弹簧圈置入动脉瘤内以填塞动脉瘤, 从而阻止血流流入动脉瘤。 弹簧圈 栓塞材料和微导管的设计可以到达迂曲复杂的脑动脉的动脉瘤病变, 且通 过瘤腔的填塞阻止血流冲击, 然而这种填塞也存在导致动脉瘤腔进一步扩 大和破裂的风险。  The detachable coil is filled with a percutaneous vascular puncture, which is introduced into the blood vessel through a microcatheter, and a metal coil is placed in the aneurysm to fill the aneurysm, thereby preventing blood flow into the aneurysm. Coil Embolization materials and microcatheters are designed to reach aneurysmal lesions that distort complex cerebral arteries and block blood flow impact through the filling of the tumor lumen. However, this packing also carries the risk of further enlargement and rupture of the aneurysm lumen.
动脉瘤治疗的目标是减少动脉瘤破裂的风险, 最根本的方法是实现母 体载瘤动脉的愈合, 动脉壁解剖结构的重构。  The goal of aneurysm treatment is to reduce the risk of aneurysm rupture. The most fundamental method is to achieve the healing of the parental artery and the reconstruction of the anatomy of the artery wall.
通过植入血管支架治疗并重构脑动脉瘤的母体载瘤动脉, 这种脑血管 的重构支架必须具备如下特点:  The reconstructed stent of the cerebral blood vessel must have the following characteristics by implanting a vascular stent to treat and reconstruct the maternal tumor-bearing artery of the cerebral aneurysm:
1 )支架可以被压缩装入微输送器内腔,压缩后支架足够柔软能够通过 迂曲、 纤细、 复杂的脑血管被输送到达靶目标;  1) The stent can be compressed into the lumen of the microconveyor. After compression, the stent is soft enough to be transported through the tortuous, slender, complex cerebrovascular vessels to the target;
2 ) 支架植入后具有足够的顺应性, 顺应迂曲的脑血管;  2) After stent implantation, it has sufficient compliance to conform to the tortuous cerebrovascular;
3 )支架网孔显著影响动脉瘤内的血流动力学, 同时维持载瘤动脉被支 架覆盖的正常分支动脉的通畅。 冠脉支架植入脑动脉瘤母血管内以辅助弹簧圈栓塞。 但是, 脑血管的解剖 形态迂曲复杂, 具有比冠脉更多的弯曲, 因此冠脉支架的刚性使其到达脑 血管非常困难。  3) The stent mesh significantly affects the hemodynamics within the aneurysm while maintaining the patency of the normal branch artery covered by the stent. The coronary stent is implanted into the cerebral artery of the cerebral aneurysm to assist the coil embolization. However, the anatomy of the cerebral blood vessels is complex and has more curvature than the coronary arteries, so the rigidity of the coronary stent makes it very difficult to reach the cerebral blood vessels.
专用颅内支架为增加支架系统的柔软性, 往往在设计上采用少量金属 覆盖和开放式的网格, 网孔面积较大。 从动物实验和长期临床随访已经证 实, 这种支架无法有效地改变动脉瘤内血流动力学, 且其扩张态支架在弯 曲血管部位存在贴壁不良, 腔内打折。 发明内容  Special intracranial stents are used to increase the softness of the stent system. They are often designed with a small amount of metal covering and an open mesh with a large mesh area. It has been confirmed from animal experiments and long-term clinical follow-up that this stent cannot effectively change the hemodynamics in the aneurysm, and the expanded stent has poor adherence in the curved vessel and is discounted in the lumen. Summary of the invention
针对上述问题, 本发明提供一种高度柔软和灵活的血管重构支架, 能 够穿越曲折纤细的脑血管到达靶病变, 并顺应迂曲的血管保持血管内腔通 道。 该支架具有高密度网孔, 可以显著改变动脉瘤内血流流动使其滞留形 成血凝块和机化固体物。 In view of the above problems, the present invention provides a highly flexible and flexible vascular remodeling stent capable of traversing a tortuous and delicate cerebral blood vessel to reach a target lesion, and conforming to a tortuous blood vessel to maintain a lumen of the blood vessel. Road. The stent has a high-density mesh that can significantly alter the flow of blood in the aneurysm to cause it to form blood clots and mechanized solids.
根据本发明的血管重构支架, 其可植入血管内用于治疗血管扩张、 变 形、 畸形等病变, 例如动脉瘤等。 具体地, 所述血管重构支架呈网管状结 构, 具有通过多根丝链相互交错编织形成的多个网孔。 其中, 每根丝链是 连续的, 网孔的节点是可移动的。 这里丝链是指丝或丝状结构。  According to the vascular remodeling stent of the present invention, it can be implanted into a blood vessel for treating a lesion such as a vasodilatation, a deformity, a deformity, or the like, such as an aneurysm or the like. Specifically, the vascular remodeling stent has a mesh tubular structure and has a plurality of meshes formed by interlacing a plurality of silk chains. Wherein each of the chains is continuous and the nodes of the mesh are movable. Here, the silk chain refers to a silk or filament structure.
所述丝链与血管重构支架的径向方向形成一角 β0, 角 β0为 15。~85。。 优选为 30。 ~ 75。, 更优选为 45。 ~ 60。, 目的是保持血管重构支架具有合适 的支撑力,同时在弯曲血管内具有最优的贴壁性和顺应性以实现血管重构。 The silk chain forms an angle β 0 with the radial direction of the vascular remodeling stent, and the angle β 0 is 15. ~85. . It is preferably 30. ~ 75. More preferably, it is 45. ~ 60. The goal is to maintain a proper support of the vascular remodeling stent while providing optimal adherence and compliance within the curved vessel for vascular remodeling.
所述血管重构支架的网孔密度大于 5pores/mm2The vascular remodeling stent has a mesh density greater than 5 pores/mm 2 .
所述血管重构支架的金属覆盖率为 12%~60%, 优选为 30%~50%, 更优选为 35%~45%。  The metal coverage of the vascular remodeling stent is 12% to 60%, preferably 30% to 50%, more preferably 35% to 45%.
根据血管重构支架的植入和治疗部位, 所述血管重构支架上不同部分 具有不同的金属覆盖率。  Depending on the implantation and treatment site of the vascular remodeling stent, different portions of the vascular remodeling stent have different metal coverage.
例如,所述血管重构支架的金属覆盖率在轴向上变化。在动脉瘤段处, 金属覆盖率为 30% ~ 50%, 在其它位置处, 金属覆盖率为 12%~20%。  For example, the metal coverage of the vascular remodeling stent varies in the axial direction. At the aneurysm segment, the metal coverage is 30% to 50%, and at other locations, the metal coverage is 12% to 20%.
或者,所述血管重构支架的金属覆盖率在周向上变化。在动脉瘤口处, 金属覆盖率为 50% ~ 60%, 在其他位置处, 金属覆盖率为 12%~20%。  Alternatively, the metal coverage of the vascular remodeling stent varies in the circumferential direction. At the aneurysm mouth, the metal coverage is 50% to 60%, and at other locations, the metal coverage is 12% to 20%.
所述血管重构支架的压缩比可达到 2: 1 - 10: 1。  The compression ratio of the vascular reconstruction scaffold can reach 2:1 - 10:1.
所述丝链根数为 8~ 108, 优选为 24~96, 更优选为 32~56, 目的是 实现血管重构支架的支撑性和柔顺性的最优平衡。  The number of strands is from 8 to 108, preferably from 24 to 96, more preferably from 32 to 56, in order to achieve an optimal balance of support and compliance of the vascular remodeling stent.
所述丝链的横截面可以是不同的形状, 例如矩形、 梯形、 圆形或椭圆 形等。  The cross-section of the wire chain may be a different shape such as a rectangle, a trapezoid, a circle or an ellipse or the like.
当丝链的横截面为圆形时,丝链的直径为 0.01 ~ 0.2mm,优选为 0.025 ~ 0.1mm, 更优选为 0.03 ~ 0.08mm。 当丝链的横截面为矩形时, 矩形的长和 宽为 0.01 ~ 0.2mm, 优选为 0.025 ~ 0.1mm, 更优选为 0.03 ~ 0.08mm, 矩形 的长宽比为 1: 1 ~4: 1。 这样确定丝链的尺寸的目的是保证血管重构支架 的丝的具有合适力学强度, 可以有效消除对颅内动脉内细小穿支动脉(穿 支动脉直径通常大于 0.1mm) 的影响。 所述丝链的节距为 0.01 ~ 3mm。根据血管重构支架的植入和治疗部位, 所述丝链可以具有不同的节距。 这里 "节距" 是指单根丝链上任意一点旋 转 2π后前进的距离。 When the cross section of the wire chain is circular, the diameter of the wire chain is 0.01 to 0.2 mm, preferably 0.025 to 0.1 mm, more preferably 0.03 to 0.08 mm. When the cross section of the wire chain is rectangular, the length and width of the rectangle are 0.01 to 0.2 mm, preferably 0.025 to 0.1 mm, more preferably 0.03 to 0.08 mm, and the aspect ratio of the rectangle is 1:1 to 4:1. The purpose of determining the size of the silk chain in this way is to ensure that the silk of the vascular remodeling stent has a suitable mechanical strength, and can effectively eliminate the influence of the small perforating artery in the intracranial artery (the diameter of the perforating artery is usually larger than 0.1 mm). The pitch of the wire chain is 0.01 to 3 mm. The silk chains can have different pitches depending on the implantation and treatment sites of the vascular remodeling stent. Here, "pitch" refers to the distance traveled by any point on a single wire chain after 2π.
所述丝链的材料可以选用生物相容性的金属或 /和聚合物。  The material of the silk chain may be a biocompatible metal or/and a polymer.
根据本发明, 上述血管重构支架可以用于支撑或遮挡动脉瘤内的栓塞 物质, 以保证栓塞物质只处于动脉瘤内, 维持载瘤动脉的通畅。  According to the present invention, the above-mentioned vascular remodeling stent can be used to support or block the embolic material in the aneurysm to ensure that the embolic material is only in the aneurysm and maintain the patency of the parent artery.
本发明的有益效果在于:  The beneficial effects of the invention are:
本发明的血管重构支架高度柔软、 灵活, 能够穿越曲折纤细的脑血管 到达靶病变, 并顺应迂曲的血管保持血管内腔通道。 而且, 连续可变的高 密度网孔可以显著改变动脉瘤内血流流动使其滞留形成血凝块和机化固体 物。 同时, 高密集度的网丝作为内皮细胞生长或移行的支撑, 能够促使内 膜生长过程加快, 而动脉瘤内血流滞留保障了内膜生长的物理条件, 使病 变血管内膜化实现真正的解剖治愈。 附图说明  The vascular remodeling stent of the present invention is highly flexible and flexible, and is capable of traversing a tortuous and delicate cerebral blood vessel to reach a target lesion, and conforms to a tortuous blood vessel to maintain a vascular lumen passage. Moreover, continuously variable high-density meshes can significantly alter blood flow in the aneurysm to cause it to form blood clots and mechanized solids. At the same time, high-density mesh as a support for endothelial cell growth or migration can accelerate the growth process of the intima, and the retention of blood flow in the aneurysm ensures the physical conditions of intimal growth, making the diseased vessel intimalization real. Anatomical cure. DRAWINGS
图 1为根据本发明的血管重构支架的优选实施例的结构示意图; 图 2为根据本发明的血管重构支架的优选实施例的结构立体图; 图 3为根据本发明的血管重构支架的优选实施例的部分放大示意图; 图 4为根据本发明的血管重构支架的优选实施例的使用示意图; 图 5a, 5b为根据本发明的血管重构支架的其它优选实施例的示意图; 图 6a _ 6d为根据本发明的血管重构支架的不同丝链的横截面示意图。 附图标记说明  1 is a schematic structural view of a preferred embodiment of a vascular remodeling stent according to the present invention; FIG. 2 is a perspective view showing a structure of a preferred embodiment of a vascular remodeling stent according to the present invention; and FIG. 3 is a vascular remodeling stent according to the present invention. A partially enlarged schematic view of a preferred embodiment; Figure 4 is a schematic illustration of the use of a preferred embodiment of a vascular remodeling stent in accordance with the present invention; Figures 5a, 5b are schematic illustrations of other preferred embodiments of a vascular remodeling stent in accordance with the present invention; _ 6d is a schematic cross-sectional view of different silk chains of a vascular remodeling stent according to the present invention. Description of the reference numerals
10, 40, 50 血管重构支架  10, 40, 50 vascular reconstruction stent
20 丝链  20 silk chain
30, 31 , 32 节点  30, 31, 32 nodes
41 , 51 动脉瘤口段  41, 51 aneurysm mouth
42, 52 其他部位  42, 52 other parts
43 , 53 瘤动脉  43 , 53 tumor artery
44, 54 分支 45 , 55 正常血管壁 具体实施方式 44, 54 branches 45, 55 normal blood vessel wall embodiment
下面结合附图详细地说明根据本发明的不同实施方式。  Different embodiments in accordance with the present invention are described in detail below with reference to the accompanying drawings.
参见图 1到图 3所示, 其示出了根据本发明的高度柔软和灵活的植入 装置: 血管重构支架 10。 图中所示血管重构支架 10为网管状结构, 通过 连续的丝链 20交错编织形成, 具有多个网孔。 丝链 20交错编织的编织点 也称作网孔的节点, 网孔的节点 30是可移动的, 或者可活动的。 支架的每 艮丝链 20与支架的径向方向形成角 β。,角 β。为 15° ~ 85°,优选为 30° ~ 75°, 更优选为 45。 ~ 60。, 这样可以提供足够的径 /环向支撑。  Referring to Figures 1 through 3, there is shown a highly flexible and flexible implant device in accordance with the present invention: a vascular remodeling stent 10. The vascular remodeling stent 10 shown in the drawing is a mesh tubular structure formed by interlacing a continuous filament chain 20 having a plurality of meshes. The braided points of the chain 20 interlaced are also referred to as the nodes of the mesh, and the nodes 30 of the mesh are movable or movable. Each of the strands 20 of the stent forms an angle β with the radial direction of the stent. , angle β. It is from 15 ° to 85 °, preferably from 30 ° to 75 °, more preferably 45. ~ 60. This provides sufficient diameter/loop support.
根据本发明的血管重构支架, 由于网孔的节点 30 是可移动的, 丝链 20并没有固定在节点上, 丝链 20之间可以相互移动。 丝链 20的相对可移 动性使支架具有足够的灵活性, 可以实现空间弯曲或扭转, 从而更接近自 然血管形态, 符合和顺应迂曲的脑血管, 同时保持血管内管腔形态。  According to the vascular remodeling stent of the present invention, since the nodes 30 of the mesh are movable, the wire chain 20 is not fixed to the nodes, and the wire chains 20 can move relative to each other. The relative mobility of the wire chain 20 allows the stent to be flexible enough to flex or twist the space to be closer to the natural vessel morphology, conforming to and conforming to the tortuous cerebrovascular vessels while maintaining the intravascular lumen morphology.
优选地, 支架的网孔密度(即单位面积上网孔的个数) 大于 5pores/ mm2Preferably, the mesh density of the stent (ie, the number of cells per unit area) is greater than 5 pores/mm 2 .
支架金属覆盖率为 12% ~ 60%, 优选为 30% ~ 50%, 更优选为 35% ~ 45%。  The stent metal coverage is 12% to 60%, preferably 30% to 50%, more preferably 35% to 45%.
编织使用的丝链的根数可以为 8 ~ 108,优选为 24 ~ 96,更优选为 32 ~ 56。 根据支架的植入和治疗部位可以具有不同根数的丝链。  The number of the chains used for weaving may be from 8 to 108, preferably from 24 to 96, more preferably from 32 to 56. Depending on the implantation and treatment site of the stent, there may be different numbers of silk chains.
丝链节距优选控制在 0.01 ~ 3mm。 支架的金属覆盖率和网孔密度都可 以通过编织丝链的根数、 尺寸、 编织节距等实现。 这里 "节距" 是指单根 丝链上任意一点旋转 2π后前进的距离。例如, 图 3中节点 31和 32之间的 距离。  The pitch of the wire chain is preferably controlled to be 0.01 to 3 mm. The metal coverage and mesh density of the stent can be achieved by the number of braided chains, the size, the weaving pitch, and the like. Here, "pitch" refers to the distance traveled by any point on a single wire chain after 2π. For example, the distance between nodes 31 and 32 in Figure 3.
如图 4所示, 本发明的支架具有柔软的连续结构和较高的可压缩性, 压缩比可达到 2: 1 ~ 10: 1 , 可以被压缩装载入管径 Φ为 0.3mm ~ 1.5mm 的输送器内, 使支架能够穿越曲折、 纤细的脑血管。  As shown in FIG. 4, the stent of the present invention has a soft continuous structure and high compressibility, and the compression ratio can reach 2:1 to 10:1, and can be compressed and loaded into the diameter Φ of 0.3 mm to 1.5 mm. Inside the conveyor, the stent can pass through the tortuous, slender cerebrovascular.
如图 5a和 5b所示, 根据本发明的另一优选实施方式, 血管重构支架 40, 50具有不均一的网格结构,即支架在不同部位具有不同的金属覆盖率。 例如, 覆盖载瘤动脉 43, 53的动脉瘤口段 41, 51具有高金属覆盖率, 以 最大限度地改变动脉瘤内血流, 而在支架其他部位 42, 52则具有低金属覆 盖率结构, 以支撑支架贴附正常血管壁 45, 55, 在保持管腔通畅的同时尽 可能地减少对分支 44, 54的覆盖面积。 As shown in Figures 5a and 5b, in accordance with another preferred embodiment of the present invention, the vascular remodeling stents 40, 50 have a non-uniform grid structure, i.e., the stents have different metal coverage at different locations. For example, the aneurysm segments 41, 51 covering the parent artery 43, 53 have a high metal coverage to maximize blood flow in the aneurysm, while the other portions of the stent 42, 52 have a low metal coverage structure. The normal vessel wall 45, 55 is attached with a support bracket to minimize the coverage of the branches 44, 54 while keeping the lumen open.
例如, 在动脉瘤段处, 金属覆盖率为 30%~50%, 在其它位置处, 金 属覆盖率为 12%~20%。  For example, at the aneurysm segment, the metal coverage is 30% to 50%, and at other locations, the metal coverage is 12% to 20%.
或者, 金属覆盖率可以在支架的周向上变化。 在动脉瘤段上的动脉瘤 口处,金属覆盖率为 50% ~ 60%,在其他位置处,金属覆盖率为 12% ~ 20%。  Alternatively, the metal coverage can vary in the circumferential direction of the stent. At the aneurysm of the aneurysm segment, the metal coverage is 50% to 60%, and at other locations, the metal coverage is 12% to 20%.
如图 6a- 6d所示,丝链的横截面可以是不同的形状,例如矩形、梯形、 圆形或椭圆形等。  As shown in Figures 6a-6d, the cross-section of the wire chain can be of a different shape, such as rectangular, trapezoidal, circular or elliptical.
此外, 这种植入装置的连续网格也可以做为动脉瘤内的栓塞物质 (如 可解脱弹簧圈、 栓塞液体等) 的支撑或遮挡, 以保证栓塞材料只处于动脉 瘤内, 从而维持载瘤动月永的通畅。  In addition, the continuous mesh of the implant device can also be used as an embolization material in the aneurysm (such as a releasable coil, embolic fluid, etc.) to support or block, to ensure that the embolic material is only in the aneurysm, thereby maintaining the tumor. The moon is always smooth.

Claims

权 利 要 求 Rights request
1. 一种血管重构支架,其特征在于,所述血管重构支架呈网管状结构, 具有通过多根丝链相互交错编织形成的多个网孔。  A vascular remodeling stent, characterized in that the vascular remodeling stent has a mesh tubular structure and has a plurality of meshes formed by interlacing a plurality of silk chains.
2. 根据权利要求 1所述的血管重构支架, 其特征在于, 所述每根丝链 是连续的。  2. The vascular remodeling stent according to claim 1, wherein each of the filament chains is continuous.
3. 根据权利要求 1所述的血管重构支架, 其特征在于, 所述网孔的节 点是可移动的。  3. The vascular remodeling stent of claim 1 wherein the nodes of the mesh are moveable.
4. 根据权利要求 1 -3 中任一项所述的血管重构支架, 其特征在于, 所述丝链与血管重构支架的径向方向形成的角 β0为 15。~85。。 The blood vessel reconstruction stent according to any one of claims 1 to 3, wherein an angle β 0 formed by the wire chain and the radial direction of the blood vessel reconstruction stent is 15. ~85. .
5. 根据权利要求 4所述的血管重构支架, 其特征在于, 所述丝链与血 管重构支架的径向方向形成的角 β0为 30°~75°。 The blood vessel reconstruction stent according to claim 4, wherein an angle β 0 formed by the wire chain and the radial direction of the blood vessel reconstruction stent is 30° to 75°.
6. 根据权利要求 5所述的血管重构支架, 其特征在于, 所述丝链与血 管重构支架的径向方向形成的角 β0为 45°~60°。 The blood vessel reconstruction stent according to claim 5, wherein an angle β 0 formed by the wire chain and the radial direction of the blood vessel reconstruction stent is 45° to 60°.
7. 根据权利要求 1 -3 中任一项所述的血管重构支架, 其特征在于, 所述血管重构支架的网孔密度大于 5pores/mm2The vascular remodeling stent according to any one of claims 1 to 3, wherein the vascular remodeling stent has a mesh density of more than 5 pores/mm 2 .
8. 根据权利要求 1 -3 中任一项所述的血管重构支架, 其特征在于, 所述血管重构支架的金属覆盖率为 12%~60%。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the vascular remodeling stent has a metal coverage of 12% to 60%.
9. 根据权利要求 8所述的血管重构支架, 其特征在于, 所述血管重构 支架的金属覆盖率为 30% ~ 50%。  The vascular remodeling stent according to claim 8, wherein the vascular remodeling stent has a metal coverage of 30% to 50%.
10. 根据权利要求 9所述的血管重构支架, 其特征在于, 所述血管重 构支架的金属覆盖率为 35%~45%。  The vascular remodeling stent according to claim 9, wherein the blood vessel remodeling stent has a metal coverage of 35% to 45%.
11. 根据权利要求 8所述的血管重构支架, 其特征在于, 根据血管重 构支架的植入和治疗部位, 所述血管重构支架上不同部分具有不同的金属 覆盖率。  11. The vascular remodeling stent of claim 8, wherein different portions of the vascular remodeling stent have different metal coverage depending on the implantation and treatment site of the revascularized stent.
12. 根据权利要求 11所述的血管重构支架, 其特征在于, 所述血管重 构支架的金属覆盖率在轴向上变化。  The vascular remodeling stent according to claim 11, wherein the metal coverage of the blood vessel remodeling stent changes in the axial direction.
13. 根据权利要求 12所述的血管重构支架, 其特征在于, 所述血管重 构支架在动脉瘤段处的金属覆盖率为 30%~50%, 在其它位置处的金属覆 盖率为 12%~20%。 The vascular remodeling stent according to claim 12, wherein the vascular remodeling stent has a metal coverage of 30% to 50% at the aneurysm segment and a metal coverage of 12 at other locations. %~20%.
14. 根据权利要求 11所述的血管重构支架, 其特征在于, 所述血管重 构支架的金属覆盖率在周向上变化。 The vascular remodeling stent according to claim 11, wherein the metal coverage of the blood vessel remodeling stent changes in the circumferential direction.
15. 根据权利要求 14所述的血管重构支架, 其特征在于, 所述血管重 构支架在动脉瘤口处的金属覆盖率为 50%~60%, 在其他位置的金属覆盖 率为 12%~20%。  The vascular remodeling stent according to claim 14, wherein the vascular reconstructing stent has a metal coverage of 50% to 60% at the aneurysm opening and a metal coverage of 12% at other locations. ~20%.
16. 根据权利要求 1 -3中任一项所述的血管重构支架, 其特征在于, 所述血管重构支架的压缩比为 2: 1 - 10: 1。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the vascular remodeling stent has a compression ratio of 2:1 - 10:1.
17. 根据权利要求 1 -3中任一项所述的血管重构支架, 其特征在于, 所述丝链根数为 8~ 108。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the number of the filament chains is 8 to 108.
18. 根据权利要求 17所述的血管重构支架, 其特征在于, 所述丝链根 数为 24~96。  The vascular remodeling stent according to claim 17, wherein the number of the silk chains is 24 to 96.
19. 根据权利要求 18所述的血管重构支架, 其特征在于, 所述丝链根 数为 32~56。  The vascular remodeling stent according to claim 18, wherein the number of the chains is 32 to 56.
20. 根据权利要求 1 -3中任一项所述的血管重构支架, 其特征在于, 所述丝链的横截面为梯形或椭圆形。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the wire chain has a trapezoidal or elliptical cross section.
21. 根据权利要求 1 -3中任一项所述的血管重构支架, 其特征在于, 所述丝链的横截面为圆形。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the wire chain has a circular cross section.
22. 根据权利要求 21所述的血管重构支架, 其特征在于, 所述丝链的 直径为 0.01 ~ 0.2mm。  The vascular remodeling stent according to claim 21, wherein the wire chain has a diameter of 0.01 to 0.2 mm.
23. 根据权利要求 22所述的血管重构支架, 其特征在于, 所述丝链的 直径为 0.025 ~ 0.1 mm。  The vascular remodeling stent according to claim 22, wherein the wire chain has a diameter of 0.025 to 0.1 mm.
24. 根据权利要求 23所述的血管重构支架, 其特征在于, 所述丝链的 直径为 0.03 ~0.08mm。  The vascular remodeling stent according to claim 23, wherein the wire chain has a diameter of 0.03 to 0.08 mm.
25. 根据权利要求 1 -3中任一项所述的血管重构支架, 其特征在于, 所述丝链的横截面为矩形。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the wire chain has a rectangular cross section.
26. 根据权利要求 25所述的血管重构支架, 其特征在于, 所述矩形的 长宽比为 1: 1 ~4: 1。  The vascular reconstruction stent according to claim 25, wherein the rectangular aspect ratio is 1: 1 to 4: 1.
27. 根据权利要求 26所述的血管重构支架, 其特征在于, 所述矩形的 长为 0.01 ~ 0.2mm, 宽为 0.01 ~ 0.2mm。 The vascular remodeling stent according to claim 26, wherein the rectangle has a length of 0.01 to 0.2 mm and a width of 0.01 to 0.2 mm.
28. 根据权利要求 27所述的血管重构支架, 其特征在于, 所述矩形的 长为 0.025 ~ 0.1mm, 宽为 0.025 ~ 0.1mm。 The vascular remodeling stent according to claim 27, wherein the rectangle has a length of 0.025 to 0.1 mm and a width of 0.025 to 0.1 mm.
29. 根据权利要求 28所述的血管重构支架, 其特征在于, 所述矩形的 长为 0.03 ~ 0.08mm, 宽为 0.03 ~ 0.08mm。  The vascular remodeling stent according to claim 28, wherein the rectangle has a length of 0.03 to 0.08 mm and a width of 0.03 to 0.08 mm.
30. 根据权利要求 1 - 3中任一项所述的血管重构支架, 其特征在于, 所述丝链的节距为 0.01 ~ 3mm。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the pitch of the silk chain is 0.01 to 3 mm.
31. 根据权利要求 30所述的血管重构支架, 其特征在于, 根据血管重 构支架的植入和治疗部位, 所述丝链具有不同的节距。  31. The vascular remodeling stent of claim 30, wherein the filament chains have different pitches depending on the implantation and treatment sites of the revascularized stent.
32. 根据权利要求 1 - 3中任一项所述的血管重构支架, 其特征在于, 所述丝链的材料为生物相容性的金属或 /和聚合物。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the material of the silk chain is a biocompatible metal or/and a polymer.
33. 根据权利要求 1 - 3中任一项所述的血管重构支架, 其特征在于, 所述支架用于支撑或遮挡动脉瘤内的栓塞物质。  The vascular remodeling stent according to any one of claims 1 to 3, wherein the stent is used to support or block an embolic material in the aneurysm.
+ +
PCT/CN2010/076333 2009-08-27 2010-08-25 Intravascular reconstructive stent WO2011023105A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910194688.0A CN101991477B (en) 2009-08-27 2009-08-27 Vascular reconstructive support frame
CN200910194688.0 2009-08-27

Publications (1)

Publication Number Publication Date
WO2011023105A1 true WO2011023105A1 (en) 2011-03-03

Family

ID=43627265

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/076333 WO2011023105A1 (en) 2009-08-27 2010-08-25 Intravascular reconstructive stent

Country Status (2)

Country Link
CN (1) CN101991477B (en)
WO (1) WO2011023105A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9050205B2 (en) 2004-05-25 2015-06-09 Covidien Lp Methods and apparatus for luminal stenting
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9125659B2 (en) 2004-05-25 2015-09-08 Covidien Lp Flexible vascular occluding device
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9320590B2 (en) 2006-02-22 2016-04-26 Covidien Lp Stents having radiopaque mesh
US9393021B2 (en) 2004-05-25 2016-07-19 Covidien Lp Flexible vascular occluding device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US10004618B2 (en) 2004-05-25 2018-06-26 Covidien Lp Methods and apparatus for luminal stenting
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant
WO2022024003A1 (en) * 2020-07-31 2022-02-03 DePuy Synthes Products, Inc. Multi-layer folding flow diverters
WO2024074525A1 (en) * 2022-10-04 2024-04-11 Acandis Gmbh Medical device, in particular stent, medical system, and method for producing a medical device

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102499732A (en) 2011-10-19 2012-06-20 微创医疗器械(上海)有限公司 Intravascular implanted device bag and preparation method for implanted device
CN102764170B (en) * 2012-07-18 2015-09-16 吕文峰 A kind of endovascular stent of complex function
US9913740B2 (en) * 2012-10-25 2018-03-13 W. L. Gore & Associates, Inc. Stent with varying cross-section
CN104720941A (en) * 2013-12-20 2015-06-24 微创神通医疗科技(上海)有限公司 Vessel stent and production method thereof
CN104274257A (en) * 2014-09-19 2015-01-14 深圳市人民医院 Nanometer electrospinning fiber stent for intravascular interventional therapy of intracranial aneurysm
CN108272481A (en) * 2016-12-30 2018-07-13 香港科技大学深圳研究院 A kind of adaptive supporting frame and its manufacturing method
CN109771097A (en) * 2019-03-11 2019-05-21 北京航空航天大学 Manpower intervention type aortic valve stent with the variation of radial support power
CN110251285B (en) * 2019-05-21 2021-06-18 泰升医疗有限公司 Tapered blood vessel support
CN110507457B (en) * 2019-08-30 2022-04-22 湖南瑞康通科技发展有限公司 Support, conveying system thereof and medical instrument

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101002702A (en) * 2006-01-16 2007-07-25 上海康德莱企业发展集团有限公司 Braided blood vessel stent with external ring-net skirt
WO2007139699A2 (en) * 2006-05-24 2007-12-06 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
US20080039933A1 (en) * 2001-07-09 2008-02-14 Surpass Medical Ltd. Implantable intraluminal device and method of using same in treating aneurysms
CN101234046A (en) * 2007-01-17 2008-08-06 Aga医药有限公司 Intravascular deliverable stent for reinforcement of vascular abnormalities
CN101732116A (en) * 2008-11-15 2010-06-16 微创医疗器械(上海)有限公司 Intravascular stent used for repairing lesion blood vessel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080039933A1 (en) * 2001-07-09 2008-02-14 Surpass Medical Ltd. Implantable intraluminal device and method of using same in treating aneurysms
CN101002702A (en) * 2006-01-16 2007-07-25 上海康德莱企业发展集团有限公司 Braided blood vessel stent with external ring-net skirt
WO2007139699A2 (en) * 2006-05-24 2007-12-06 Chestnut Medical Technologies, Inc. Flexible vascular occluding device
CN101234046A (en) * 2007-01-17 2008-08-06 Aga医药有限公司 Intravascular deliverable stent for reinforcement of vascular abnormalities
CN101732116A (en) * 2008-11-15 2010-06-16 微创医疗器械(上海)有限公司 Intravascular stent used for repairing lesion blood vessel

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10765542B2 (en) 2004-05-25 2020-09-08 Covidien Lp Methods and apparatus for luminal stenting
US9801744B2 (en) 2004-05-25 2017-10-31 Covidien Lp Methods and apparatus for luminal stenting
US9855047B2 (en) 2004-05-25 2018-01-02 Covidien Lp Flexible vascular occluding device
US11771433B2 (en) 2004-05-25 2023-10-03 Covidien Lp Flexible vascular occluding device
US9295568B2 (en) 2004-05-25 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US10918389B2 (en) 2004-05-25 2021-02-16 Covidien Lp Flexible vascular occluding device
US9050205B2 (en) 2004-05-25 2015-06-09 Covidien Lp Methods and apparatus for luminal stenting
US9393021B2 (en) 2004-05-25 2016-07-19 Covidien Lp Flexible vascular occluding device
US10004618B2 (en) 2004-05-25 2018-06-26 Covidien Lp Methods and apparatus for luminal stenting
US9125659B2 (en) 2004-05-25 2015-09-08 Covidien Lp Flexible vascular occluding device
US9320590B2 (en) 2006-02-22 2016-04-26 Covidien Lp Stents having radiopaque mesh
US9610181B2 (en) 2006-02-22 2017-04-04 Covidien Lp Stents having radiopaque mesh
US10433988B2 (en) 2006-02-22 2019-10-08 Covidien Lp Stents having radiopaque mesh
US11382777B2 (en) 2006-02-22 2022-07-12 Covidien Lp Stents having radiopaque mesh
US9907643B2 (en) 2012-10-30 2018-03-06 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9114001B2 (en) 2012-10-30 2015-08-25 Covidien Lp Systems for attaining a predetermined porosity of a vascular device
US9301831B2 (en) 2012-10-30 2016-04-05 Covidien Lp Methods for attaining a predetermined porosity of a vascular device
US10952878B2 (en) 2012-10-31 2021-03-23 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9452070B2 (en) 2012-10-31 2016-09-27 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US10206798B2 (en) 2012-10-31 2019-02-19 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9943427B2 (en) 2012-11-06 2018-04-17 Covidien Lp Shaped occluding devices and methods of using the same
US9561122B2 (en) 2013-02-05 2017-02-07 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US9157174B2 (en) 2013-02-05 2015-10-13 Covidien Lp Vascular device for aneurysm treatment and providing blood flow into a perforator vessel
US10888414B2 (en) 2019-03-20 2021-01-12 inQB8 Medical Technologies, LLC Aortic dissection implant
WO2022024003A1 (en) * 2020-07-31 2022-02-03 DePuy Synthes Products, Inc. Multi-layer folding flow diverters
US11911259B2 (en) 2020-07-31 2024-02-27 DePuy Synthes Products, Inc. Multi-layer folding flow diverters
WO2024074525A1 (en) * 2022-10-04 2024-04-11 Acandis Gmbh Medical device, in particular stent, medical system, and method for producing a medical device

Also Published As

Publication number Publication date
CN101991477A (en) 2011-03-30
CN101991477B (en) 2014-03-26

Similar Documents

Publication Publication Date Title
WO2011023105A1 (en) Intravascular reconstructive stent
US11291453B2 (en) Filamentary devices having a flexible joint for treatment of vascular defects
JP7327726B2 (en) Filament device for treatment of vascular disorders
JP7469323B2 (en) Filamentous Devices for the Treatment of Vascular Disorders - Patent application
AU2013231845B2 (en) Stent and stent delivery device
JP4540912B2 (en) Endovascular graft system
US20170128077A1 (en) Devices for therapeutic vascular procedures
US9918720B2 (en) Multiple layer filamentary devices for treatment of vascular defects
EP3600068B1 (en) Devices for embolization of body structures
KR20120123121A (en) Surgical apparatus for aneurysms
WO2015160721A1 (en) Devices for therapeutic vascular procedures
JP2012500711A (en) Stent-graft with expanded attachment area and method of using the same
US10321985B2 (en) Vascular prosthesis system
JP6290097B2 (en) Intracavity artificial blood vessel
EP3908354A1 (en) Filamentary devices for treatment of vascular defects
JP2007307409A (en) Aneurysm treatment device
US20210007754A1 (en) Filamentary devices for treatment of vascular defects
JP2011244926A (en) Stent
RU2460500C1 (en) Device of implant for human and animal vessels
WO2010054604A1 (en) Intravascular stent for repairing diseased blood vessel
CN215651351U (en) Aneurysm plugging device and aneurysm plugging system
US20230039773A1 (en) Implant for treating aneurysms
CN113952094A (en) Detachable branch support for bifurcation
JP2012024479A (en) Stent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10811265

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10811265

Country of ref document: EP

Kind code of ref document: A1